CNS Pharmaceuticals, Inc. (CNSP) Dividend History

Company News

• IBN Announces Latest Episode of The BioMedWire Podcast featuring John Climaco, CEO of CNS Pharmaceuticals Inc.

  CNS Pharmaceuticals, a biopharmaceutical company, is developing novel treatments for brain and central nervous system cancers. The company's lead drug candidate, Berubicin, is in a late-stage pivotal trial, and it has recently in-licensed another promising drug, TPI-287, for glioblastoma treatment.

  GlobeNewswire Inc.
• Top 5 Health Care Stocks That Are Preparing To Pump In February

  The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here’s the latest list of major oversold players in this sector, having an RSI near or below 30. BIOLASE, Inc. (NASDAQ: BIOL) On Jan. 29, Biolase reported full-year 2023 interim revenue of $48.9 million to $49.2 million, up 1% year-over-year compared to the consensus of $49.21 million. The company’s stock fell around 43% over the past five days ...

  Benzinga

  Featured Companies: GILD REVB
• Essential Penny Stock Trading Tools: Maximizing Efficiency

  Use these tips for trading penny stocks efficiently The post Essential Penny Stock Trading Tools: Maximizing Efficiency appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

  PennyStocks

  Featured Companies: AEMD
• 'Gradually, then suddenly.' Earnings expectations may be about to drop, says Morgan Stanley strategist.

  Morgan Stanley's Mike Wilson is worried that investors have waved an all-clear to fallout from the banking crisis.

  MarketWatch

  Featured Companies: AAPL AMC AMRX BAC COMP DJIA GME GS MRK MRNA MS MTB MULN NFLX SCHW STT TSLA
• Is CNS Pharmaceuticals, Inc. (CNSP) Outperforming Other Medical Stocks This Year?

  Here is how CNS Pharmaceuticals, Inc. (CNSP) and Celyad SA (CYAD) have performed compared to their sector so far this year.

  Zacks Investment Research